Henan Lingrui Pharmaceutical Co Ltd (600285) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Henan Lingrui Pharmaceutical Co Ltd (600285) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥140.12 Million ≈ $20.50 Million USD) by net assets (CN¥3.28 Billion ≈ $480.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Henan Lingrui Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Henan Lingrui Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Henan Lingrui Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Lingrui Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Neinor Homes SLU
MC:HOME
0.154x
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
0.048x
Three's Company Media Group Co Ltd
SHG:605168
-0.021x
Shenzhen Bromake New Material Co. Ltd. A
SHE:301387
N/A
Pebblebrook Hotel Trust
NYSE:PEB
0.033x
CBIZ Inc
NYSE:CBZ
-0.013x
Aether Industries Limited
NSE:AETHER
0.047x
Zhejiang DiAn Diagnostics Co
SHE:300244
0.069x

Annual Cash Flow Conversion Efficiency for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Henan Lingrui Pharmaceutical Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.44 Billion
≈ $502.78 Million
CN¥553.88 Million
≈ $81.05 Million
0.161x -43.31%
2024-12-31 CN¥3.08 Billion
≈ $450.74 Million
CN¥875.86 Million
≈ $128.17 Million
0.284x -2.17%
2023-12-31 CN¥2.80 Billion
≈ $409.54 Million
CN¥813.43 Million
≈ $119.03 Million
0.291x -10.94%
2022-12-31 CN¥2.56 Billion
≈ $374.38 Million
CN¥834.91 Million
≈ $122.17 Million
0.326x -11.77%
2021-12-31 CN¥2.29 Billion
≈ $334.60 Million
CN¥845.69 Million
≈ $123.75 Million
0.370x +90.63%
2020-12-31 CN¥2.32 Billion
≈ $339.80 Million
CN¥450.53 Million
≈ $65.93 Million
0.194x -4.30%
2019-12-31 CN¥2.22 Billion
≈ $324.92 Million
CN¥450.15 Million
≈ $65.87 Million
0.203x -2.67%
2018-12-31 CN¥2.09 Billion
≈ $306.49 Million
CN¥436.25 Million
≈ $63.84 Million
0.208x +333.20%
2017-12-31 CN¥2.20 Billion
≈ $322.52 Million
CN¥105.97 Million
≈ $15.51 Million
0.048x +60.53%
2016-12-31 CN¥2.11 Billion
≈ $309.08 Million
CN¥63.26 Million
≈ $9.26 Million
0.030x -67.07%
2015-12-31 CN¥1.72 Billion
≈ $252.28 Million
CN¥156.82 Million
≈ $22.95 Million
0.091x +14.19%
2014-12-31 CN¥1.56 Billion
≈ $228.39 Million
CN¥124.32 Million
≈ $18.19 Million
0.080x -38.36%
2013-12-31 CN¥984.89 Million
≈ $144.12 Million
CN¥127.27 Million
≈ $18.62 Million
0.129x +483.53%
2012-12-31 CN¥696.97 Million
≈ $101.99 Million
CN¥15.43 Million
≈ $2.26 Million
0.022x -62.59%
2011-12-31 CN¥684.01 Million
≈ $100.09 Million
CN¥40.49 Million
≈ $5.92 Million
0.059x +1163.14%
2010-12-31 CN¥709.69 Million
≈ $103.85 Million
CN¥-3.95 Million
≈ $-578.20K
-0.006x -102.71%
2009-12-31 CN¥645.69 Million
≈ $94.48 Million
CN¥132.61 Million
≈ $19.40 Million
0.205x +158.23%
2008-12-31 CN¥549.72 Million
≈ $80.44 Million
CN¥43.72 Million
≈ $6.40 Million
0.080x +188.20%
2007-12-31 CN¥579.24 Million
≈ $84.76 Million
CN¥15.99 Million
≈ $2.34 Million
0.028x -49.82%
2006-12-31 CN¥486.67 Million
≈ $71.21 Million
CN¥26.76 Million
≈ $3.92 Million
0.055x -21.07%
2005-12-31 CN¥479.80 Million
≈ $70.21 Million
CN¥33.43 Million
≈ $4.89 Million
0.070x -7.89%
2004-12-31 CN¥469.45 Million
≈ $68.70 Million
CN¥35.51 Million
≈ $5.20 Million
0.076x +43.63%
2003-12-31 CN¥451.69 Million
≈ $66.10 Million
CN¥23.79 Million
≈ $3.48 Million
0.053x -68.38%
2002-12-31 CN¥416.74 Million
≈ $60.98 Million
CN¥69.41 Million
≈ $10.16 Million
0.167x +1861.90%
2001-12-31 CN¥401.79 Million
≈ $58.79 Million
CN¥3.41 Million
≈ $499.14K
0.008x -5.34%
2000-12-31 CN¥408.46 Million
≈ $59.77 Million
CN¥3.66 Million
≈ $536.06K
0.009x -88.42%
1999-12-31 CN¥62.08 Million
≈ $9.08 Million
CN¥4.81 Million
≈ $703.65K
0.077x --

About Henan Lingrui Pharmaceutical Co Ltd

SHG:600285 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.67 Billion
CN¥11.41 Billion CNY
Market Cap Rank
#6943 Global
#1560 in China
Share Price
CN¥20.12
Change (1 day)
-1.61%
52-Week Range
CN¥20.12 - CN¥24.46
All Time High
CN¥26.75
About

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orth… Read more